Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors.

[1]  D. Trono,et al.  Editing at the Crossroad of Innate and Adaptive Immunity , 2005, Science.

[2]  P. Bieniasz.  Intrinsic immunity: a front-line defense against viral attack , 2004, Nature Immunology.

[3]  L. Naldini,et al.  Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors. , 2004, Virology.

[4]  S. Banerjee,et al.  An engineered EBV vector expressing human factor VIII and von Willebrand factor in cultured B‐cells , 2004, The journal of gene medicine.

[5]  J. Imbert,et al.  Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  R. Skoda,et al.  Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells. , 2004, Blood.

[7]  A. Mantovani,et al.  The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. , 2003, Blood.

[8]  A. Lanzavecchia,et al.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. , 2003, Blood.

[9]  R. Coffman,et al.  Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions , 2003, Journal of leukocyte biology.

[10]  D. Trono,et al.  Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. , 2003, Blood.

[11]  C. von Kalle,et al.  Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. , 2003, Blood.

[12]  W. Janssens,et al.  Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. , 2003, Human gene therapy.

[13]  Pascal Schneider,et al.  Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex , 2003, Molecular and Cellular Biology.

[14]  D. Trono,et al.  Modalities of Interleukin-7-Induced Human Immunodeficiency Virus Permissiveness in Quiescent T Lymphocytes , 2002, Journal of Virology.

[15]  J. Tschopp,et al.  IgG subclass switch capacity is low in switched and in IgM‐only, but high in IgD+IgM+, post‐germinal center (CD27+) human B cells , 2001, European journal of immunology.

[16]  D. Trono,et al.  High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. , 2000, Blood.

[17]  Inder M. Verma,et al.  Gene therapy: trials and tribulations , 2000, Nature Reviews Genetics.

[18]  D. Trono,et al.  Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[20]  D. Littman,et al.  Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes , 1999, The Journal of experimental medicine.

[21]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[22]  R. V. van Lier,et al.  Control of lymphocyte function through CD27-CD70 interactions. , 1998, Seminars in immunology.

[23]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[24]  C. Snapper,et al.  Efficient recombination of a switch substrate retrovector in CD40-activated B lymphocytes: implications for the control of CH gene switch recombination. , 1998, Journal of immunology.

[25]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[26]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[27]  V. Kindler,et al.  Human naive B cells cultured with EL‐4 T cells mimic a germinal center‐related B cell stage before generating plasma cells. Concordant changes in Bcl‐2 protein and messenger RNA levels , 1997, European journal of immunology.

[28]  H. Varmus,et al.  Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection , 1996, Journal of virology.

[29]  V. Kindler,et al.  Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs , 1993, The Journal of experimental medicine.

[30]  K. Weinberg,et al.  Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. , 2000, Blood.

[31]  A. Lanzavecchia,et al.  IMMUNOBIOLOGY A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR , 2022 .